The mechanism of benzene-induced leukemia: A hypothesis and speculations on the causes of leukemia

Environmental Health Perspectives

Volumn 104, Issue SUPPL. 6, 1996, Pages 1219-1225

  Smith, Martyn T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aneuploidy; Benzenetriol; Carcinogenesis; Chromosome damage; Free radicals; Hydroquinone; L eukemia; Oxygen radicals; Phenol; Quinones; Recombination; Topoisomerase

Indexed keywords

BENZENE; DNA TOPOISOMERASE (ATP HYDROLYSING); HISTONE; HYDROQUINONE; PEROXIDASE; PHENOL; PHENOL DERIVATIVE; PROTEIN; QUINONE DERIVATIVE; RADICAL; REACTIVE OXYGEN METABOLITE; SEMIQUINONE; TUBULIN;

ANEUPLOIDY; BLOOD CELL; CELL SURVIVAL; CHROMOSOME TRANSLOCATION; CONFERENCE PAPER; DNA STRAND BREAKAGE; GENE FUSION; GENE MUTATION; LEUKEMIA; LIVER; MITOSIS RATE; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTO ONCOGENE; STEM CELL; STROMA; SUPPRESSOR GENE;

EID: 0030473213     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041219     Document Type: Conference Paper

References (63)

1. Lutz W. Quantitative evaluation of DNA binding data for risk estimation and for classification of direct and indirect carcinogens. Cancer Res Clin Oncol 112:85-91 (1986).
2. Dean BJ. Recent findings on the genetic toxicology of benzene, toluene, xylenes and phenols. Mutat Res 154:153-81 (1985).
3. Sasiadek M, Jagielski J. Genotoxic effects observed in workers occupationally exposed to organic solvents. Pol J Occup Med 3:103-108 (1990).
4. Wolman SR. Cytologic and cytogenetic effects of benzene. J Toxicol Environ Health Suppl 2:63-68 (1977).
5. Yager JW, Eastmond DA, Robertson ML, Paradisin WM, Smith MT. Characterization of micronuclei induced in human lymphocytes by benzene metabolites. Cancer Res 50:393-399 (1990).
6. Goldstein BD, Witz G, Javid J, Amoruso MA, Rossman T. Muconaldehyde, a potential toxic intermediate of benzene metabolism. Adv Exp Med Biol 136A:331-339 (1982).
7. Glatt H, Witz G. Studies on the induction of gene mutations in bacterial and mammalian cells by the ring-opened benzene metabolites trans,trans-muconaldehyde and trans,trans-muconic acid. Mutagenesis 5:263-266 (1990).
8. Brodfuehrer JI, Chapman DE, Wilke TJ, Powis G. Comparative studies of the in vitro metabolism and covalent binding of C-benzene by liver slices and microsomal fraction of mouse, rat, and human. Drug Metab Dispos 18:20-27 (1990).
9. Orzechowski A, Schwarz L, Schwegler U, Bock K, Snyder R, Schrenki D. Benzene metabolism in rodent hepatocytes: role of sulphate conjugation. Xenotiotica 25:1093-1102 (1995).
10. Zhang L, Robertson ML, Kolachana P, Davison AJ, Smith MT. Benzene metabolite, 1,2,4-benzenetriol, induces micronuclei and oxidative DNA damage in human lymphocytes and HL60 cells. Environ Mol Mutagen 21:339-48 (1993).
11. Zhang L, Smith MT, Bandy B, Tamaki SJ, Davison AJ. Role of quinones, active oxygen species and metals in the genotoxicity of 1,2,4-benzenetriol, a metabolite of benzene. In: Free Radicals in the Environment, Medicine and Toxicology. Vol 8 (Nohl H, Esterbauer H, Rice-Evans C, eds). London:Richelieu 1994;521-562.
12. Guy RL, Peidi H, Witz G, Goldstein BD, Snyder R. Depression of iron uptake into erythrocytes in mice by treatment with the combined benzene metabolites p-benzoquinone, muconaldehyde and hydroquinone. J Appl Toxicol 11:443-446 (1991).
13. Medinsky MA, Kenyon EM, Seaton, MJ, Schlosser PM. Mechanistic considerations in benzene physiological model development. Environ Health Perspect 104 (Suppl 6): 1399-1404 (1996).
14. Bois F, Smith M, Spear R. Mechanisms of benzene carcinogenesis: application of a physiological model of benzene pharmaco-kinetics and metabolism to Hypothesis testing. Toxicol Lett 00:283-298 (1991).
15. Henderson RF. Species differences in the metabolism of benzene. Environ Health Perspect 104 (Suppl 6):1173-1175 (1996).
16. Eastmond DA, Smith MT, Irons RD. An interaction of benzene metabolites reproduces the myelotoxicity observed with benzene exposure. Toxicol Appl Pharmacol 91:85-95 (1987).
17. Smith MT, Yager JW, Steinmetz KM, Eastmond DA. Peroxidase-dependent metabolism of benzene's phenolic metabolites and its potential role in benzene toxicity and carcinogenicity. Environ Health Perspect 82:23-29 (1989).
18. Subrahmanyam V, Doane-Setzer P, Steinmetz K, Ross D, Smith M. Phenol-induced stimulation of hydroquinone bioactivation in mouse bone marrow in vivo: possible implications in benzene myelotoxicity. Toxicology 62:107-116 (1990).
19. Subrahmanyam W, Kolachana P, Smith MT. Metabolism of hydroquinone by human myeloperoxidase: mechanisms of stimulation by other phenolic compounds. Arch Biochem Biophys 286:76-84 (1991).
20. Robertson M, Eastmond D, Smith MT. Two benzene metabolites, catechol and hydroquinone, produce a synergistic genotoxic response in cultured human lymphocytes. Mutat Res 249:201-209 (1990).
21. Barale R, Marrazzini A, Betti C, Vangelisti V, Loprieno N, Barrai I. Genotoxicity of two metabolites of benzene: phenol and hydroquinone show strong synergistic effects in vivo. Mutat Res 244:15-20 (1990).
22. Levay G, Bodell WJ. Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites. Proc Natl Acad Sci USA 89:7105-7109 (1992).
23. Kolachana P, Subrahmanyam W, Meyer KB, Zhang L, Smith MT. Benzene and its phenolic metabolites produce oxidative DNA damage in HL60 cells in vitro and in the bone marrow in vivo. Cancer Res 53:1023-1026 (1993).
24. Low L, Lambert C, Meeks J, Naro P, Mackerer C. Tissue-specific metabolism of benzene in Zymbal gland and other solid tumor target tissues in rats. J Am Coll Toxicol 14:40-60 (1995).
25. Subrahmanyam VV, Ross D, Eastmond DA, Smith MT. Potential role of free radicals in benzene-induced myelotoxicity and leukemia. Free Rad Biol Med 11:495-515 (1991).
26. Lagorio S, Tagesson C, Forastiere F, Iavarone I, Axelson O, Carere A. Exposure to benzene and urinary concentrations of 8-hydroxydeoxyguanosine, a biological marker of oxidative damage to DNA. Occup Environ Med 51:739-43 (1994).
27. Plappert U, Barthel E, Raddatz K, Seidel HJ. Early effects of benzene exposure in mice. Hematological versus genotoxic effects. Arch Toxicol 68:284-290 (1994).
28. Lee EW, Garner CD. Effects of benzene of DNA strand breaks in vivo versus benzene metabolite-induced DNA strand breaks in vitro in mouse bone marrow cells. Toxicol Appl Pharmacol 108:497-508 (1991).
29. Mackerer C, Blackburn G, Reddy M, Angelosanto F. Benzene Mechanistic Research Project: Final Report. Princeton, NJ:Mobil Oil Corporation, 1991.
30. Chen H, Eastmond D. Topoisomerase inhibition by phenolic metabolites: a potential mechanism for benzene's clastogenic effects. Carcinogenesis 16:1963-1969 (1995).
31. Frantz CE, Chen H, Eastmond DA. Inhibition of human topoisomerase II in vitro by bioactive benzene metabolites. Environ Health Perspect 104 (Suppl 6):1319-1323 (1996).
32. Anderson RD, Berger NA. International Commission for Protection against Environmental Mutagens and Carcinogens. Mutagenicity and carcinogenicity of topoisomerase-interactive agents. Mutat Res 309:109-42 (1994).
33. Whitlock JA, Greer JP, Lukens JN. Epipodophyllotoxin-related leukemia. Identification of a new subset of secondary leukemia. Cancer 68:600-604 (1991).
34. Chen AY, Liu LF. DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218 (1994).
35. Felix C, Lange B, Hosler M, Fertala J, Bjornsti M-A. Chromosome band 11q23 translocation breakpoints are DNA topoisomerase II cleavage sites. Cancer Res 55:4287-4292 (1995).
36. Greaves M. A natural history for pediatric acute leukemia. Blood 82:1043-1051 (1993).
37. Rothman N, Haas R, Hayes RB, Li GL, Wiemels J, Campleman S, Quintana PJ, Xi LJ, Dosemeci M, Titenko-Holland N, Meyer KB, Lu W, Zhang L, Bechtold W, Wang YZ, Kolachana P, Yin SN, Blot W, Smith MT. Benzene induces gene-duplicating but not gene-inactivating mutations at the glycophorin A locus in exposed humans. Proc Natl Acad Sci USA 92:4069-4073 (1995).
38. Kagan J. Molecular biology of chromosomal aberrations in leukemia/lymphoma. Hematol Pathol 7:159-201 (1993).
39. Rabbitts TH. Chromosomal translocations in human cancer. Nature 372:143-149 (1994).
40. Nucifora G, Rowley JD. AML1 and the 8;21 and 3;21 translocations in acute and chronic myeloid leukemia. Blood 86:1-14 (1995).
41. Downing JR, Head DR, Curcio-Brint AM, Hulshof MG, Motroni TA, Raimondi SC, Carroll AJ, Drabkin HA, Willman C, Theil KS. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 81:2860-2865 (1993).
42. Erickson PF, Robinson M, Owens G, Drabkin HA. The ETO portion of acute myeloid leukemia t(8;21) fusion transcript encodes a highly evolutionarily conserved, putative transcription factor. Cancer Res 54:1782-1786 (1994).
43. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 83:2780-2786 (1994).
44. Rothman N, Smith MT, Hayes RB, Li G-L, Irons RD, Dosemeci M, Haas R, Stillman WS, Linet M, Xi L-Q, Bechtold WE, Wiemels J, Campleman L, Zhang L, Quintana PJE, Titenko-Holland N, Wang Y-Z, Lu W, Kolachana P, Meyer KB, Yin S-N. An epidemiologic study of benzene's early biologic effects in heavily exposed workers in Shanghai, China. Environ Health Perspect 104 (Suppl 6):1365-1370 (1996).
45. Smith M, Rothman N, Zhang L, Wang Y, Hayes R, Yin S-N. Molecular cytogenetics of humans exposed to benzene. Toxicologist 30:Abstr 911 (1996).
46. Mitelman F, Nilsson PG, Brandt L, Alimena G, Gastaldi R, Dallapiccola B. Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia. Cancer Genet Cytogenet 4:197-214 (1981).
47. Li Y-S, Zhao Y-L, Jiang Q-P, Yang C-L. Specific chromosome changes and nonoccupational exposure to potentially carcinogenic agents in acute leukemia in China. Leuk Res 13:367-376 (1989).
48. Zhang L, Venkatesh P, Creek MLR, Smith MT. Detection of 1,2,4-benzenetriol induced aneuploidy and microtubule disruption by fluorescence in situ hybridization and immunocytochemistry. Mutat Res 320:315-327 (1994).
49. Eastmond DA, Rupa DS, Hasegawa LS. Detection of hyperdiploidy and chromosome breakage in interphase human lymphocytes following exposure to the benzene metabolite hydroquinone using multicolor fluorescence in situ hybridization with DNA probes. Mutat Res 322:9-20 (1994).
50. Zhang LP, Rothman N, Wang X, Hayes RB, Bechtold W, Venkatesh P, Yin S, Wang Y, Dosemeci M, Li G, Lu W, Smith MT. Interphase cytogenetics of workers exposed to benzene. Environ Health Perspect 104 (Suppl 6):1325-1329 (1996).
51. Irons RD, Stillman WS. The process of leukemogenesis. Environ Health Perspect 104 (Suppl 6):1239-1246 (1996).
52. Oshimura M, Barrett JC. Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer. Environ Mutagen 8:129-159 (1986).
53. Bond DJ. Mechanisms of aneuploid induction. Mutat Res 181:257-66 (1987).
54. Irons RD, Neptune DA. Effects of the prinicipal hydroxymetabolites of benzene on microrubule polymerization. Arch Toxicol 45:297-305 (1980).
55. Irons RD, Pfeifer RW, Aune TM, Pierce CW. Soluble immune response suppressor (SIRS) inhibits microtubule function in vivo and microtubule assembly in vitro. J Immunol 133:2032-2036 (1984).
56. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 61:759-767 (1990).
57. Renz JF, Kalf GF. Role for interleukin-1 (IL-1) in benzene-induced hematotoxicity: inhibition of conversion of pre-IL-1 alpha to mature cytokine in murine macrophages by hydroquinone and prevention of benzene-induced hematotoxicity in mice by IL-1 alpha. Blood 78:938-944 (1991).
58. Irons RD, Stillman WS, Colagiovanni DB, Henry VA. Synergistic action of the benzene metabolite hydroquinone on myelopoietic stimulating activity of granulocyte/macrophage colony-stimulating factor in vitro. Proc Natl Acad Sci USA 89:3691-3695 (1992).
59. Irons RD, Stillman WS. Cell proliferation and differentiation in chemical leukemogenesis. Stem Cells 11:235-242 (1993).
60. Lau SH, OA, Highet R, Monks T. Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution. Mol Pharmacol 34:829-836 (1988).
61. 6]benzene. Cancer Res 54:4907-4914 (1994).
62. Smith M. Mechanistic studies of benzene toxicity: implications for risk assessment. In: Biological Reactive Intermediates V (Synder R, Sipes GI, Kalf GF, eds). New York:Plenum Press, 1995;259-266.
63. Smith MT, Quinones as mutagens, carcinogens, and anticancer agents: introduction and overview. J Toxicol Environ Health 16:665-672 (1985).